PortfoliosLab logoPortfoliosLab logo
TNXP vs. META
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TNXP vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tonix Pharmaceuticals Holding Corp. (TNXP) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TNXP achieves a -27.02% return, which is significantly lower than META's -5.54% return. Over the past 10 years, TNXP has underperformed META with an annualized return of -84.70%, while META has yielded a comparatively higher 18.15% annualized return.


TNXP

1D
-2.73%
1M
-12.51%
YTD
-27.02%
6M
-35.88%
1Y
-71.82%
3Y*
-87.63%
5Y*
-89.37%
10Y*
-84.70%

META

1D
4.24%
1M
2.06%
YTD
-5.54%
6M
-2.44%
1Y
-6.29%
3Y*
32.06%
5Y*
13.70%
10Y*
18.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TNXP vs. META - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TNXP
Tonix Pharmaceuticals Holding Corp.
-27.02%-52.64%-97.44%-83.46%-96.59%-47.01%-42.31%-94.68%-93.62%-26.61%
META
Meta Platforms, Inc.
-5.54%13.09%66.05%194.13%-64.22%23.13%33.09%56.57%-25.71%53.38%

Correlation

The correlation between TNXP and META is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since May 21, 2012

0.15

Fundamentals

Market Cap

TNXP:

$156.26M

META:

$1.60T

EPS

TNXP:

-$11.15

META:

$27.47

PS Ratio

TNXP:

6.24

META:

7.45

PB Ratio

TNXP:

0.69

META:

6.55

Total Revenue (TTM)

TNXP:

$17.56M

META:

$214.96B

Gross Profit (TTM)

TNXP:

$10.28M

META:

$176.14B

EBITDA (TTM)

TNXP:

-$149.18M

META:

$106.31B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TNXP vs. META — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TNXP
TNXP Risk / Return Rank: 99
Overall Rank
TNXP Sharpe Ratio Rank: 88
Sharpe Ratio Rank
TNXP Sortino Ratio Rank: 66
Sortino Ratio Rank
TNXP Omega Ratio Rank: 88
Omega Ratio Rank
TNXP Calmar Ratio Rank: 77
Calmar Ratio Rank
TNXP Martin Ratio Rank: 1717
Martin Ratio Rank

META
META Risk / Return Rank: 3232
Overall Rank
META Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
META Sortino Ratio Rank: 2929
Sortino Ratio Rank
META Omega Ratio Rank: 2929
Omega Ratio Rank
META Calmar Ratio Rank: 3434
Calmar Ratio Rank
META Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TNXP vs. META - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tonix Pharmaceuticals Holding Corp. (TNXP) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TNXPMETADifference
Sharpe ratioReturn per unit of total volatility

-0.63

Sortino ratioReturn per unit of downside risk

-1.49

Omega ratioGain probability vs. loss probability

0.84

1.00

-0.16

Calmar ratioReturn relative to maximum drawdown

-0.88

-0.19

-0.69

Martin ratioReturn relative to average drawdown

-1.13

-0.41

-0.72

TNXP vs. META - Sharpe Ratio Comparison

The current TNXP Sharpe Ratio is -0.81, which is lower than the META Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of TNXP and META, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TNXPMETADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.81

-0.18

-0.63

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.66

0.31

-0.97

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.60

0.47

-1.07

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.58

0.56

-1.14

Drawdowns

TNXP vs. META - Drawdown Comparison

The maximum TNXP drawdown since its inception was -100.00%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for TNXP and META.


Loading charts...

Drawdown Indicators


TNXPMETADifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-76.74%

-23.26%

Max Drawdown (1Y)

Largest decline over 1 year

-81.48%

-33.30%

-48.18%

Max Drawdown (3Y)

Largest decline over 3 years

-99.88%

-34.15%

-65.73%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

-76.74%

-23.26%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

-76.74%

-23.26%

Current Drawdown

Current decline from peak

-100.00%

-20.96%

-79.04%

Average Drawdown

Average peak-to-trough decline

-91.16%

-15.25%

-75.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

63.70%

15.47%

+48.23%

Volatility

TNXP vs. META - Volatility Comparison

Tonix Pharmaceuticals Holding Corp. (TNXP) has a higher volatility of 25.96% compared to Meta Platforms, Inc. (META) at 8.84%. This indicates that TNXP's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TNXPMETADifference

Volatility (1M)

Calculated over the trailing 1-month period

25.96%

8.84%

+17.12%

Volatility (6M)

Calculated over the trailing 6-month period

52.37%

26.58%

+25.79%

Volatility (1Y)

Calculated over the trailing 1-year period

88.75%

35.23%

+53.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

136.01%

43.99%

+92.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

140.91%

38.64%

+102.27%

Dividends

TNXP vs. META - Dividend Comparison

TNXP has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.34%.


PositionTTM20252024
META
Meta Platforms, Inc.
0.34%0.32%0.34%
TNXP
Tonix Pharmaceuticals Holding Corp.
0.00%0.00%0.00%

Financials

TNXP vs. META - Financials Comparison

This section allows you to compare key financial metrics between Tonix Pharmaceuticals Holding Corp. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B60.00B20222023202420252026
6.88M
56.31B
(TNXP) Total Revenue
(META) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TNXP and META have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TNXP has higher volatility (25.96%) compared to META (8.84%). In terms of maximum drawdown, TNXP dropped -100.00% vs META's -76.74%.

META currently has the higher Sharpe Ratio (-0.18 vs -0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TNXP and META

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer